Product Images Ganciclovir

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Ganciclovir NDC 51754-2500 by Exela Pharma Sciences, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Creatinine Clearance Formulas - spl image1 formula

Creatinine Clearance Formulas - spl image1 formula

This text provides a formula to calculate creatinine clearance for males and females based on age, body weight, and serum creatinine levels. Specifically, for males, the formula is (140-age in years) multiplied by body weight in kilograms, divided by 72 times serum creatinine level in milligrams per deciliter. For females, the formula is 0.85 times the male value.*

Structure - spl image2 structure

Structure - spl image2 structure

The text represents the chemical structure of the drug ganciclovir. Ganciclovir is an antiviral medication used to treat certain viral infections, including cytomegalovirus (CMV) infection.*

Figure 1 - spl image3 figure1

Figure 1 - spl image3 figure1

Figure 2 - spl image4 figure2

Figure 2 - spl image4 figure2

The text appears to be a chart or graph showing the proportion of patients who do not experience progression of CMV retinitis over time during maintenance therapy. It includes a time axis in days up to 120 days.*

Figure 3 - spl image5 figure3

Figure 3 - spl image5 figure3

The text appears to be a graph or chart related to the time to progression of CMV retinitis. It shows the proportion of individuals without progression of the disease over time from the start of maintenance therapy. Unfortunately, the text is not fully legible, so a more detailed description cannot be provided.*

Container Label Bag - spl image6 label bag 500mg

Container Label Bag - spl image6 label bag 500mg

This is a description of Ganciclovir Injection, which is contained in a single-dose bag of 250ml 0.8% sodium chloride solution. The bag, with the drug for intravenous use only, contains 500mg per 250ml (2mg per ml) and must be discarded once the dose has been administered. The pH of the solution may be adjusted using hydrochloric acid and/or sodium hydroxide to attain 5. The recommended storage conditions are between 20°C to 25°C (68°F to 77°F), with excursions allowed up to 30°C (86°F). The package should not be used if there is a leak, and any residue should be delicately dissolved by shaking the bag. Check the package insert for dosing and administering information and dose instructions. It is not for use in series connections, and additional medications must not be added to the solution.*

Label Overwrap - spl image7 label overwrap 500mg

Label Overwrap - spl image7 label overwrap 500mg

Ganciclovir Injection is a medication administered in a single-dose container of 250mL. Each mL of this injection contains 2mg of ganciclovir and 8mg of sodium chloride in water for injection, along with sodium hydroxide and/or hydrochloric acid to adjust the pH to 7.5. Please refer to the package insert for complete information on dosage and administration. It is vital to check for minute leaks by squeezing the bag firmly, and gentle shaking should be done to redissolve any crystals that may have formed during transportation or storage at temperatures lower than recommended. The medication is not suitable for use in series connections and should not have any supplementary medication added to it. Store the medication at 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). This medication is manufactured and distributed by Exela Pharma Sciences and must be used with caution.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.